2-chloroacrylic acid, 98% +(stabilized with 0.3-0.5% BHT), 5g

5-amino-2-(tetrahydro-2-furanylmethyl)-1H-isoindole-1,3(2H)-dione, 95.0%, 1g

4-Ethoxy-2-methylsulfanyl-6-(piperidin-2-ylmethoxy)-pyrimidine hydrochloride, 95.0%, 250mg

(1r,1's,4R,4'R)-4-Ethoxy-4'-propyl-1,1'-bi(cyclohexane), 95.0%, 100mg

(S)-N-4-Boc-N-1-Cbz-2-Piperazine carboxylic acid, 98.0%, 250mg

1-Chloro-6,7-dimethoxyisoquinoline, 95.0%, 100mg

tert-Butyl 4-nitro-1H-pyrazole-1-carboxylate, 95%, 10g

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline, 95.0%, 1g

1-Benzyl-5-bromo-1H-indole, 97.0%, 1g

15-Bromo-1-pentadecanol, 95.0%, 250mg

3-Chloro-2-methyl-1-propene (stabilized with Stearyl 3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionate)>98.0%(GC)25mL

Étalon d'indice de réfraction, ROTI®Calipure, 1.44468 (20 °C), 15 ml, emballage en verre

4-Pyridinamine, 2,6-dichloro-3-fluoro-, 98%, 250mg